Results 171 to 180 of about 1,947,649 (260)

Responding to medetomidine in Philadelphia: narrative summary of the public health response to a new psychoactive substance. [PDF]

Addict Sci Clin Pract
Warrick-Stone T, Simpson SE, Durney P, Goodstein D, Abrams C, Bobb R, London K, Teixeira da Silva D.   +7 more
europepmc   +1 more source

Baxter's Street

, 1972
Baxter's Street
core  

Drug use disorders among people convicted of large‐, moderate‐ and small‐scale drug supply crimes: A register‐based retrospective comparative study

Addiction, EarlyView.
Abstract Background and aims Heavy drug use has been associated with small‐scale drug crime, but the substance use histories of individuals involved in the manufacturing, smuggling and wholesaling of larger quantities of drugs [here referred to as serious drug crimes (SDC)] have been largely unexamined.
Julie Elizabeth Brummer, Freja Ilsing Magnussen, Morten Hesse, Thomas Friis Søgaard   +3 more
wiley   +1 more source

Recalibrating Therapeutic Priorities for Duchenne Muscular Dystrophy: A Critical Synthesis of Approved and Emerging Strategies Through the Lens of an Underrepresented Population. [PDF]

Genes (Basel)
Khaidarov S, Moldakaryzova A, Dautov D, Sagatbayeva N, Yeszhan B, Nurgaliyeva B, Kenbayeva S, Abdullayeva G, Rabandiyarov M, Tazhibayeva KN, Sadykova A, Yermekbay A, Aidarov A, Aidarov D, Aidarova A, Kurbaniyazova S, Abiyrova N, Kulmaganbetov M.   +17 more
europepmc   +1 more source

Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology

Addiction, EarlyView.
Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke, Johan Duflou, Agata Chrzanowska, Michael Farrell, Julia Lappin, Amy Peacock   +5 more
wiley   +1 more source

Police experiences with cannabis legalization and perceptions of broader drug policy reform. [PDF]

Int J Drug Policy
Silberzahn BE, Schneider KE, Sisson LN, Winiker AK, Weiss M, Pozo BD, Rouhani S.   +6 more
europepmc   +1 more source

Adolescent use of nicotine pouches in four Latin American countries: A cross‐sectional survey

Addiction, EarlyView.
Abstract Background and Aim Nicotine pouches are novel products with rapid global sales growth. Our aim was to explore use and perceptions of nicotine pouches among adolescents in Latin America. Design Cross‐sectional school surveys between March and August 2025. Setting Sixteen cities, four each in Argentina, Guatemala, Mexico and Peru.
Georgia Alexandrou, Crawford Moodie, Catherine Best, Inti Barrientos‐Gutierrez, Carlos Miguel Aguilar, Mariel Palacios, James F. Thrasher   +6 more
wiley   +1 more source

Intranasal Mucosal Atomiser Devices: A Novel Harm Reduction Intervention. [PDF]

Drug Alcohol Rev
Green H, Naren T, Chapman B, Lloyd-Jones M, Crawford S, Membrey D.   +5 more
europepmc   +1 more source

Problems in comparing tobacco regulatory models and excise when only two countries are considered

Addiction, EarlyView.
Simon Chapman, Sam Egger, Becky Freeman
wiley   +1 more source

The association between chronic pain and non‐fatal overdose in people who inject drugs: Longitudinal cohort study in Montreal, Canada, 2017 to 2025

Addiction, EarlyView.
Abstract Background and aims The prevalence of chronic pain is elevated among people who inject drugs. Chronic pain may motivate drug use, potentially increasing the risk of non‐fatal overdose. We aimed to estimate the association between chronic pain and non‐fatal overdose in people who inject drugs.
Sarah Larney, Geng Zang, Harika Dasari, M. Gabrielle Pagé, Farzaneh Vakili, Adelina Artenie, Valérie Martel‐Laferrière, Nanor Minoyan, Sasha Udhesister, Julie Bruneau   +9 more
wiley   +1 more source